惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Jina AI
Jina AI
云风的 BLOG
云风的 BLOG
人人都是产品经理
人人都是产品经理
T
The Blog of Author Tim Ferriss
阮一峰的网络日志
阮一峰的网络日志
罗磊的独立博客
J
Java Code Geeks
博客园 - 聂微东
B
Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
WordPress大学
WordPress大学
腾讯CDC
L
LangChain Blog
Apple Machine Learning Research
Apple Machine Learning Research
Microsoft Azure Blog
Microsoft Azure Blog
D
DataBreaches.Net
The GitHub Blog
The GitHub Blog
美团技术团队
博客园 - Franky
Google DeepMind News
Google DeepMind News
V
V2EX
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
月光博客
月光博客
The Cloudflare Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Tenon Medical, Inc. (TNON) Q1 2026 Earnings Call Transcript
2026-05-13 · via All Articles on Seeking Alpha

Q1: 2026-05-12 Earnings Summary

EPS of -$0.31 misses by $0.01

 | 

Revenue of

$1.38M

(89.94% Y/Y)

beats by $83.50K

Tenon Medical, Inc. (TNON) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT

Company Participants

Steven Foster - CEO, President & Director
Kevin Williamson - CFO & Secretary

Conference Call Participants

Scott Henry - Alliance Global Partners, Research Division
Anthony Vendetti - Maxim Group LLC, Research Division

Presentation

Operator

Greetings, and welcome to the Tenon Medical First Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this conference call is being recorded. Your hosts today are Steve Foster, President and Chief Executive Officer; and Kevin Williamson, Chief Financial Officer. Mr. Foster and Mr. Williamson will present results of operations for the first quarter ended March 31, 2026, and provide a corporate update.

A press release detailing these results was released today and is available on the Investor Relations section of our company's website, www.tenonmed.com. Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates and other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. For a more complete discussion of these factors and other risks, you should review our quarterly and annual reports on file with the Securities and Exchange Commission at www.sec.gov.

At this time, I'll turn the call over to Tenon Medical's Chief Executive Officer, Steve Foster. Please go ahead, sir.